Ascend Wellness Holdings, Inc.
Company Information
Industry
Medicinal Chemicals & Botanical Products
SIC Code
2833
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
44 WHIPPANY ROAD, SUITE 101, MORRISTOWN, NJ, 07960
Mailing Address
44 WHIPPANY ROAD, SUITE 101, MORRISTOWN, NJ, 07960
Phone
(646) 661-7600
Fiscal Year End
1231
EIN
830602006
Financial Overview
FY2025 FY
$561.60M
Revenue
$-0.24
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| DEF 14A Definitive proxy statement | March 20, 2026 | View on SEC |
| 8-K Current report of material events | March 12, 2026 | View on SEC |
| 10-K Annual financial report | March 12, 2026 | View on SEC |
| 8-K Current report of material events | February 13, 2026 | View on SEC |
| 8-K Current report of material events | February 9, 2026 | View on SEC |
| 8-K Current report of material events | February 6, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | December 19, 2025 | View on SEC |
| 8-K Current report of material events | November 10, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 10, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 7, 2025 | View on SEC |
Annual Reports
10-K
March 12, 2026
- Strong revenue growth: $420 million net revenue, a 12% increase YoY.
- Improved operational performance: Adjusted EBITDA up 25% to $78 million, and net loss reduced from $90 million to $65 million.
Related Companies
Companies in the same industry (SIC: 2833)
MANNATECH INC
MTEX
Medicinal Chemicals & Botanical Products
Charlie's Holdings, Inc.
CHUC
Medicinal Chemicals & Botanical Products
Tilray Brands, Inc.
TLRY
Medicinal Chemicals & Botanical Products
Synergy CHC Corp.
SNYR
Medicinal Chemicals & Botanical Products
Canopy Growth Corp
CGC
Medicinal Chemicals & Botanical Products
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.